Beijing Gobroad Hospital

This study tests a new medicine called MTM-H-001 in 75 adults with B-cell-related autoimmune diseases such as lupus, multiple sclerosis, and rheumatoid arthritis. The goal is to see if the drug is safe and can help control disease activity. Participants will receive the drug and …

This study looks at whether taking zanubrutinib (a targeted drug) after CAR-T cell therapy can help keep non-Hodgkin B-cell lymphoma from coming back. About 40 adults who have already had or are about to have CAR-T therapy will take zanubrutinib as a maintenance treatment. The ma…

This early-stage trial is testing a new treatment called CT0494BCP for people with advanced stomach or gastroesophageal junction cancer who have already tried other treatments. The therapy uses specially engineered immune cells (CAR-T cells) to attack the cancer. The study will e…

This study tests a new drug called SHR-A1904 in people with advanced neuroendocrine carcinoma that has worsened after standard treatment. The goal is to see if the drug can shrink tumors and control the disease. About 23 adults aged 18-75 will receive the drug, and researchers wi…